A patented active ingredient
Pep2Dia® is a patented milk protein hydrolysate containing AP dipeptides which inhibit alpha-glucosidase. This digestive enzyme hydrolyses polysaccharides into glucose, aiding their absorption. The action of inhibiting alpha-glucosidase enables blood sugar levels to be regulated.
Scientifically proven to reduce blood sugar levels
The relationship between the consumption of dairy products and a reduction in the risk of developing diabetes has long been recognized. Pep2Dia® was created following several years of research by the partnership between Ingredia and the LIENSs laboratory, a National Centre for Scientific Research at the University of La Rochelle, and has been tested in pre-clinical and clinical studies. Taken before a meal by individuals who are prediabetic, Pep2Dia® significantly reduces postprandial (post-meal) blood sugar levels.
Pep2Dia® has been developed in order to reduce the blood glucose levels of people who are prediabetic, which are higher than normal.
Postprandial blood sugar levels reduction
Pep2Dia® can easily be used in dietary supplements (capsules).